News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
684,646 Results
Type
Article (51011)
Company Profile (215)
Press Release (633420)
Section
Business (191002)
Career Advice (2974)
Deals (34828)
Drug Delivery (109)
Drug Development (78757)
Employer Resources (172)
FDA (16631)
Job Trends (15332)
News (329442)
Policy (32122)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (2)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (16)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (1)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (6)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2890)
Academic (1)
Accelerated approval (3)
Adcomms (26)
Allergies (85)
Alliances (51400)
ALS (93)
Alzheimer's disease (1435)
Antibody-drug conjugate (ADC) (124)
Approvals (16619)
Artificial intelligence (266)
Autoimmune disease (19)
Automation (14)
Bankruptcy (322)
Best Places to Work (12355)
BIOSECURE Act (18)
Biosimilars (104)
Biotechnology (154)
Bladder cancer (64)
Brain cancer (25)
Breast cancer (261)
Cancer (2081)
Cardiovascular disease (172)
Career advice (2485)
Career pathing (32)
CAR-T (155)
Cell therapy (433)
Cervical cancer (20)
Clinical research (63610)
Collaboration (825)
Compensation (456)
Complete response letters (25)
COVID-19 (2726)
CRISPR (43)
C-suite (225)
Cystic fibrosis (104)
Data (2005)
Decentralized trials (2)
Denatured (28)
Depression (42)
Diabetes (259)
Diagnostics (6772)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (41)
Drug discovery (120)
Drug pricing (105)
Drug shortages (24)
Duchenne muscular dystrophy (88)
Earnings (72290)
Editorial (36)
Employer branding (21)
Employer resources (151)
Events (107375)
Executive appointments (676)
FDA (17781)
Featured Employer (61)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (725)
Gene editing (110)
Generative AI (26)
Gene therapy (307)
GLP-1 (714)
Government (4537)
Grass and pollen (5)
Guidances (46)
Healthcare (20378)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (120)
Indications (27)
Infectious disease (2867)
Inflammatory bowel disease (142)
Inflation Reduction Act (10)
Influenza (51)
Intellectual property (91)
Interviews (568)
IPO (16646)
IRA (40)
Job creations (3434)
Job search strategy (2072)
Kidney cancer (10)
Labor market (25)
Layoffs (458)
Leadership (19)
Legal (7429)
Liver cancer (68)
Lung cancer (300)
Lymphoma (131)
Machine learning (4)
Management (63)
Manufacturing (282)
MASH (65)
Medical device (14357)
Medtech (14362)
Mergers & acquisitions (18724)
Metabolic disorders (652)
Multiple sclerosis (75)
NASH (21)
Neurodegenerative disease (91)
Neuropsychiatric disorders (26)
Neuroscience (1944)
NextGen: Class of 2025 (7161)
Non-profit (4967)
Northern California (2481)
Now hiring (33)
Obesity (342)
Opinion (249)
Ovarian cancer (75)
Pain (87)
Pancreatic cancer (78)
Parkinson's disease (140)
Partnered (22)
Patents (214)
Patient recruitment (96)
Peanut (50)
People (55432)
Pharmaceutical (48)
Pharmacy benefit managers (19)
Phase I (19943)
Phase II (28093)
Phase III (20964)
Pipeline (1064)
Podcasts (82)
Policy (111)
Postmarket research (2366)
Preclinical (8379)
Press Release (70)
Prostate cancer (94)
Psychedelics (33)
Radiopharmaceuticals (264)
Rare diseases (392)
Real estate (5748)
Recruiting (69)
Regulatory (22221)
Reports (29)
Research institute (2591)
Resumes & cover letters (477)
Rett syndrome (3)
RNA editing (4)
RSV (43)
Schizophrenia (70)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (56)
Southern California (2160)
Special edition (12)
Spinal muscular atrophy (154)
Sponsored (31)
Startups (3634)
State (2)
Stomach cancer (12)
Supply chain (60)
The Weekly (52)
United States (21987)
Vaccines (719)
Venture capitalists (35)
Webinars (12)
Weight loss (230)
Women's health (30)
Worklife (17)
Date
Today (217)
Last 7 days (719)
Last 30 days (2908)
Last 365 days (35285)
2025 (8517)
2024 (36895)
2023 (42134)
2022 (53454)
2021 (58154)
2020 (56905)
2019 (50195)
2018 (38025)
2017 (33963)
2016 (32790)
2015 (38280)
2014 (28888)
2013 (23849)
2012 (25699)
2011 (26390)
2010 (24049)
Location
Africa (899)
Alabama (55)
Alaska (7)
Arizona (182)
Arkansas (14)
Asia (40475)
Australia (7221)
California (5658)
Canada (1898)
China (487)
Colorado (256)
Connecticut (275)
Delaware (133)
Europe (93537)
Florida (846)
Georgia (206)
Idaho (60)
Illinois (537)
India (24)
Indiana (302)
Iowa (8)
Japan (143)
Kansas (101)
Kentucky (27)
Louisiana (9)
Maine (68)
Maryland (880)
Massachusetts (4382)
Michigan (230)
Minnesota (390)
Mississippi (2)
Missouri (84)
Montana (31)
Nebraska (26)
Nevada (57)
New Hampshire (68)
New Jersey (1636)
New Mexico (30)
New York (1624)
North Carolina (992)
North Dakota (8)
Northern California (2481)
Ohio (200)
Oklahoma (15)
Oregon (36)
Pennsylvania (1282)
Puerto Rico (9)
Rhode Island (27)
South America (1240)
South Carolina (19)
South Dakota (1)
Southern California (2160)
Tennessee (94)
Texas (845)
Utah (175)
Virginia (134)
Washington D.C. (57)
Washington State (536)
West Virginia (3)
Wisconsin (56)
684,646 Results for "gyros protein technologies gyros ab merged with protein technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gyros Protein Technologies Introduces Gyrolab Generic Anti-AAV Kit to Support Gene Therapy Development
Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers today announced the introduction of its Gyrolab® Generic Anti-Adeno Associated Virus (AAV) Kit.
June 17, 2024
·
2 min read
Press Releases
Gyros Protein Technologies Introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to Support Biotherapeutic Development
February 5, 2025
·
2 min read
Drug Development
Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessment
Gyros Protein Technologies AB announced the introduction of Gyrolab® Generic Rodent Anti-Drug Antibody Kit Reagents for the detection of circulating immune complexes of human IgG with rodent anti-human IgG.
May 2, 2024
·
2 min read
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution
Gyros Protein Technologies AB and Biotage announced a partnership to offer Biotage® PeptiPEC, based on Gyros’ PurePep® EasyClean catch and release technology, on Biotage® Extrahera™ automated sample preparation system.
December 7, 2023
·
2 min read
Gyros Protein Technologies Introduces PurePep EasyClean Auto Kit for Automated Parallel Peptide Purification
Gyros Protein Technologies AB announced the launch of its PurePep® EasyClean Auto Kit for the automated parallel purification of peptides, accelerating downstream processes for research, development, and production of simple to complex peptide drugs and therapies.
July 27, 2023
·
2 min read
Gyros Protein Technologies Introduces Gyrolab Generic Cyno ADA Kit Reagents to Support Pre-Clinical Immunogenicity Assessment
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.
May 2, 2023
·
2 min read
Gyros Protein Technologies Adds Gyrolab® Biomarker Kits to Expand Range of Ready-to-Use Kits and Reagents
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, introduced Gyrolab® Human Cytokine Kit Reagents, the first in a range of new biomarker kits.
November 29, 2022
·
2 min read
Sponsored
SignalChem’s Tau Proteins: Accelerating Neurodegenerative Disease Research
SignalChem Biotech provides diverse recombinant Tau proteins for research, helping advance tau-targeted therapies that may modify disease progression in Alzheimer’s and related tauopathies.
November 18, 2024
·
3 min read
Press Releases
Matwings Technology Raised Series A Funding of Tens of Millions USD to Redefine Protein Design
December 26, 2024
·
3 min read
Gyros Protein Technologies introduces PurePep Sonata+ peptide synthesizer
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, announced the launch of PurePep® Sonata®+, a mid-pilot scale peptide synthesizer.
March 2, 2022
·
2 min read
1 of 68,465
Next
